Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

61.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.2K
Antibody Structure and Classes01:25

Antibody Structure and Classes

4.1K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
4.1K
Antibody Actions01:26

Antibody Actions

1.3K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ProphDR: An Interpretable Deep Learning Model for Predicting Cancer Drug Response via Multi-Omics and Cross-Attention Mechanisms.

Journal of chemical information and modeling·2026
Same author

Age-dependent prognostic value of biological age for metastasis and survival in gastrointestinal cancer.

Scientific reports·2026
Same author

Generative AI for controllable protein sequence design: A survey.

npj drug discovery·2026
Same author

Unified heterogeneity-aware benchmark of drug synergy prediction: a cross-study analysis of traditional machine learning and graph deep learning models.

Journal of cheminformatics·2026
Same author

Association of liver enzyme abnormalities and tobacco exposure with unexplained recurrent spontaneous abortion risk: A case-control study.

The Journal of international medical research·2026
Same author

Target Perturbation of Genetically Proxied Antidiabetic Drug Targets and Pneumonia Risk: A Mendelian Randomization Analysis.

Current topics in medicinal chemistry·2026

Related Experiment Video

Updated: Sep 10, 2025

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.5K

S2ALM: Sequence-Structure Pre-trained Large Language Model for Comprehensive Antibody Representation Learning.

Mingze Yin1,2, Hanjing Zhou3, Jialu Wu4

  • 1College of Computer Science and Technology, Zhejiang University, Hangzhou, China.

Research (Washington, D.C.)
|August 21, 2025
PubMed
Summary

The new Sequence-Structure multi-level pre-trained Antibody Language Model (S2ALM) integrates antibody sequence and structure for improved therapeutic development. This advanced model enhances understanding and design of antibodies for various diseases.

More Related Videos

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.6K
Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies
05:27

Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies

Published on: January 26, 2019

23.8K

Related Experiment Videos

Last Updated: Sep 10, 2025

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.5K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.6K
Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies
05:27

Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies

Published on: January 26, 2019

23.8K

Area of Science:

  • Biotechnology
  • Computational Biology
  • Immunology

Background:

  • Antibodies are crucial for health and disease treatment, with biomedical language models showing promise.
  • Current models lack explicit consideration of antibody structural information, limiting their predictive power.
  • Both 1D sequence and 3D structure offer complementary insights into antibody function.

Purpose of the Study:

  • To propose a unified antibody language model, S2ALM, that integrates both sequential and structural information.
  • To develop a hierarchical pre-training paradigm with customized objectives for comprehensive antibody representations.
  • To demonstrate S2ALM's utility in various downstream tasks, including binding affinity prediction and therapeutic antibody design.

Main Methods:

  • Developed the Sequence-Structure multi-level pre-trained Antibody Language Model (S2ALM).
  • Employed a hierarchical pre-training paradigm with two customized multi-level training objectives.
  • Pre-trained S2ALM on a large dataset of 75 million sequences and 11.7 million structures.

Main Results:

  • S2ALM's representation space reveals functional binding mechanisms, evolutionary properties, and structural interaction patterns.
  • Achieved state-of-the-art performance in predicting antigen-antibody binding affinities and B cell maturation stages.
  • Demonstrated success in identifying crucial antibody binding sites and designing novel coronavirus-binding antibodies.

Conclusions:

  • S2ALM effectively models comprehensive and generalized antibody representations by integrating sequence and structure.
  • The model shows significant potential for advancing therapeutic antibody development and addressing unmet needs.
  • S2ALM outperforms existing baselines across diverse antibody understanding and generation tasks.